Table 1.
Baseline characteristics
| Characteristica | Value (n (%)) |
|---|---|
| Men | 42 (84) |
| Age (years) | 63 ± 11 |
| Aetiology | |
| Ischemic | 27 (54) |
| Dilated cardiomyopathy | 23 (46) |
| Co‐morbidity | |
| Hypertension | 49 (98) |
| Diabetes | 17 (34) |
| Dyslipidaemia | 34 (68) |
| COPD | 2 (4) |
| Systolic BP (mmHg) | 125 ± 18 |
| Diastolic BP (mmHg) | 76 ± 10 |
| Heart rate (1/min) | 66 ± 8 |
| Heart rhythm | |
| Sinus rhythm | 41 (82) |
| Atrial fibrillation | 8 (16) |
| Pacemaker | 1 (2) |
| BMI (kg/m2) | 29 ± 5 |
| NYHA | |
| I | 17 (35) |
| II | 28 (57) |
| III | 4 (8) |
| LVEF | 35 ± 7 |
| 6 MWT (m) | 491 ± 91 |
| Sodium (mmol/L (135–145)) | 140 ± 3 |
| Potassium (mmol/L (3.5–4.8)) | 4.4 ± 0.5 |
| eGFR (mL/min/1.73m2 (90–150)) | 79 ± 22 |
| Urea (mmol/L (<7.515)) | 6.85 ± 2.17 |
| Hemoglobin (mmol/L (♂: 8.073–10.557; ♀: 7.452–9.315)) | 8.82 ± 0.75 |
| Treatment | |
| Beta blocker | 49 (98) |
| ACE inhibitor | 32 (64) |
| ARB | 21 (42) |
| Aldosterone Antagonist | 25 (50) |
| Ivabradine | 3 (6) |
| Aspirine | 16 (32) |
| ICD | 14 (28) |
| Pacemaker | 1 (2) |
| CRT | 3 (6) |
a
Values in parentheses represent normal range values in the local laboratory.
ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; eGFR, estimated glomerular filtration rate using the Modification of Diet in Renal Disease equation; ICD, implantable cardioverter defibrillator; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association functional class; 6 MWT, 6 minute walk test;.